Literature DB >> 26344153

Trends in Mesh Use for Pelvic Organ Prolapse Repair From the Medicare Database.

Lily C Wang1, Bashir Al Hussein Al Awamlh1, Jim C Hu1, Melissa A Laudano1, Wesley L Davison1, Michael L Schulster1, Fujun Zhao2, Bilal Chughtai1, Richard K Lee3.   

Abstract

OBJECTIVE: To investigate recent trends in mesh use for pelvic organ prolapse (POP)-related reconstruction procedures.
MATERIALS AND METHODS: Using the 2001-2011 5% Medicare claims database, we identified POP diagnoses and related procedures. Transvaginal mesh use and sacrocolpopexy were first reported in 2005 and 2004, respectively.
RESULTS: A total of 613,160 cases of vaginal and abdominal POP repair procedures were identified. The majority of procedures involved multiple compartments. The rate of mesh use increased dramatically from 2% of repairs in 2005 to 35% by 2008. After the Food and Drug Administration warning in 2008, mesh use plateaued and then decreased in 2011. Mesh was used more commonly in younger (odds ratio [OR] 0.722, P < .001), white (OR 0.712-0.791 for other races, P < .001) women in the South (OR 0.741-0.848 for non-South regions, P < .001). Starting in 2008, the rate of sacrocolpopexy procedures almost doubled yearly until 2011. Sacrocolpopexy was more common in younger patients (49% in women <70 years) and in white women (88%); the majority of sacrocolpopexies were performed in the South (60%) and laparoscopically (83%-98%).
CONCLUSION: The treatment of POP has changed over time. The use of mesh increased significantly until 2008, after which it plateaued following the Food and Drug Administration warning regarding mesh-related complications. Concurrently, the number of sacrocolpopexy procedures increased significantly starting in 2008 as the use of laparoscopic and/or robotic technique and concern regarding transvaginal mesh increased.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26344153     DOI: 10.1016/j.urology.2015.08.022

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  9 in total

Review 1.  Robotic Sacrocolpopexy-Is It the Treatment of Choice for Advanced Apical Pelvic Organ Prolapse?

Authors:  Janine L Oliver; Ja-Hong Kim
Journal:  Curr Urol Rep       Date:  2017-09       Impact factor: 3.092

Review 2.  Making surgery safer through adequate communication with the stakeholders: vaginal slings.

Authors:  Sandra Elmer; Janelle Brennan; Rebecca Mathieson; Briony Norris; Marcus Carey; Caroline Dowling
Journal:  World J Urol       Date:  2019-07-04       Impact factor: 4.226

3.  One-Year Outcomes After Minimally Invasive Sacrocolpopexy.

Authors:  Kimberly Kenton; Elizabeth R Mueller; Christopher Tarney; Catherine Bresee; Jennifer T Anger
Journal:  Female Pelvic Med Reconstr Surg       Date:  2016 Sep-Oct       Impact factor: 2.091

4.  Rate of Pelvic Organ Prolapse Surgery Among Privately Insured Women in the United States, 2010-2013.

Authors:  Anne G Sammarco; Carolyn W Swenson; Neil S Kamdar; Emily K Kobernik; John O L DeLancey; Brahmajee Nallamothu; Daniel M Morgan
Journal:  Obstet Gynecol       Date:  2018-03       Impact factor: 7.661

5.  Reoperation rates for pelvic organ prolapse repairs with biologic and synthetic grafts in a large population-based cohort.

Authors:  Ericka M Sohlberg; Kai B Dallas; Brannon T Weeks; Christopher S Elliott; Lisa Rogo-Gupta
Journal:  Int Urogynecol J       Date:  2019-07-12       Impact factor: 2.894

6.  Mesh Exposure Following Vaginal Versus Laparoscopic Hysterectomy at the Time of Sacrocolpopexy.

Authors:  Katherine L Woodburn; Amr Sherif El Haraki; Andrew I Sokol; Robert E Gutman; Catherine A Matthews
Journal:  Int Urogynecol J       Date:  2022-02-14       Impact factor: 1.932

7.  Trends in internet search activity, media coverage, and patient-centered health information after the FDA safety communications on surgical mesh for pelvic organ prolapse.

Authors:  Benjamin V Stone; James C Forde; Valerie B Levit; Richard K Lee; Alexis E Te; Bilal Chughtai
Journal:  Int Urogynecol J       Date:  2016-05-21       Impact factor: 2.894

8.  The impact of fellowship surgical training on operative time and patient morbidity during robotics-assisted sacrocolpopexy.

Authors:  Charelle M Carter-Brooks; Angela L Du; Michael J Bonidie; Jonathan P Shepherd
Journal:  Int Urogynecol J       Date:  2017-09-09       Impact factor: 2.894

9.  Laparoscopic High Uterosacral Ligament Suspension vs. Laparoscopic Sacral Colpopexy for Pelvic Organ Prolapse: A Case-Control Study.

Authors:  Giuseppe Campagna; Lorenzo Vacca; Giovanni Panico; Giuseppe Vizzielli; Daniela Caramazza; Riccardo Zaccoletti; Monia Marturano; Roberta Granese; Martina Arcieri; Stefano Cianci; Giovanni Scambia; Alfredo Ercoli
Journal:  Front Med (Lausanne)       Date:  2022-03-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.